Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
31 May, 2026, 05.00 PM IST
What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
29 May, 2026, 06.56 PM IST
From diapers to drugs: How India's global corporate hubs are putting AI to workHeads of several Global Capability Centres (GCCs) told Reuters they are deploying AI across a host of functions - from marketing and conten...
29 May, 2026, 08.19 AM IST
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
10 May, 2026, 08.50 AM IST
AstraZeneca targets 2024 growth but mixed views hit sharesIn almost a decade since AstraZeneca fended off a takeover by U.S. rival Pfizer, CEO Pascal Soriot has rebuilt the Anglo-Swedish drugmaker'...
09 Feb, 2024, 12.15 AM IST
AstraZeneca sets up clinical data insights division in IndiaThe Bengaluru-based clinical data and insights (CDI) division is a critical advancement to support a growing global portfolio and build on ...
20 Oct, 2021, 01.41 PM IST
AstraZeneca hits snag in Covid drug developmentThe drug, made from a combination of two antibodies, failed its main goal to treat Covid-19 symptoms in exposed patients, AstraZeneca said ...
15 Jun, 2021, 05.12 PM IST
AstraZeneca sells cholesterol drug rights to Grünenthal for $320 millionAstraZeneca, which is among the front-runners in the race to develop a vaccine for the novel coronavirus, has been trying to focus on its c...
01 Dec, 2020, 01.27 PM IST
Dr Reddy's trades steady, shrugs off legal challengeDRL’s generic version was to be marketed as Ticaflo, according to those in the know.
25 Jul, 2018, 11.00 AM IST
AstraZeneca sues DRL on patentCopies of the drug can be manufactured only after all the patents covering it expire, AstraZeneca’s counsel argued in court on Tuesday.
24 Jul, 2018, 10.57 PM IST
High Court rejects AstraZeneca’s diabetes drug pleaThe Delhi High Court has dismissed AstraZeneca’s plea to block Hyderabadbased Lee Pharma from making copies of its anti-diabetes drug Ongly...
30 Jul, 2015, 04.39 AM IST
AstraZeneca inaugurates global technology centre in ChennaiThe company is also looking to develop additional technology centres with a second GTC planned for San Francisco in 2015.
16 Sep, 2014, 06.45 PM IST
Good cancer drug data helps AstraZeneca in Pfizer fightBritain's second-biggest drugmaker has rejected a $106 billion approach from its US rival Pfizer, arguing that it has a bright future.
15 May, 2014, 02.20 PM IST
- Cognizant inks multi-year agreement with AstraZeneca
Cognizant has inked a deal with AstraZeneca to deliver comprehensive biostatistics and medical reporting services for generating clinical s...
30 Nov, 2011, 05.06 PM IST
- Jubilant Biosys receives milestone payment from AstraZeneca
Earlier this week Jubilant Biosys along with US-based Endo Pharmaceuticals received an undisclosed milestone payment for their joint progra...
23 Jun, 2011, 03.57 PM IST
- Ranbaxy strikes deal on Nexium with AstraZeneca
Ranbaxy has entered into a series of out-of-court settlements with AstraZeneca with estimates of a revenue upside of $1.25-1.5 billion. Go ...
16 Apr, 2008, 02.00 AM IST
- AstraZeneca to get drugs made in India
AstraZeneca, Britain’s second largest pharmaceutical company, is planning to outsource all its drug manufacturing activities to India and o...
18 Sep, 2007, 02.50 AM IST